This company has been marked as potentially delisted and may not be actively trading. Xyratex (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. MBRX, EQ, PRPH, IBIO, ME, UBX, SYBX, BCTX, MRKR, and BOLTShould you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include Moleculin Biotech (MBRX), Equillium (EQ), ProPhase Labs (PRPH), iBio (IBIO), 23andMe (ME), Unity Biotechnology (UBX), Synlogic (SYBX), BriaCell Therapeutics (BCTX), Marker Therapeutics (MRKR), and Bolt Biotherapeutics (BOLT). These companies are all part of the "pharmaceutical preparations" industry. Xyratex vs. Moleculin Biotech Equillium ProPhase Labs iBio 23andMe Unity Biotechnology Synlogic BriaCell Therapeutics Marker Therapeutics Bolt Biotherapeutics Moleculin Biotech (NASDAQ:MBRX) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends. Do analysts rate MBRX or XRTX? Moleculin Biotech presently has a consensus price target of $6.00, indicating a potential upside of 530.91%. Given Moleculin Biotech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Moleculin Biotech is more favorable than Xyratex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moleculin Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Xyratex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in MBRX or XRTX? Moleculin Biotech received 75 more outperform votes than Xyratex when rated by MarketBeat users. However, 63.41% of users gave Xyratex an outperform vote while only 49.36% of users gave Moleculin Biotech an outperform vote. CompanyUnderperformOutperformMoleculin BiotechOutperform Votes23149.36% Underperform Votes23750.64% XyratexOutperform Votes15663.41% Underperform Votes9036.59% Do institutionals & insiders hold more shares of MBRX or XRTX? 15.5% of Moleculin Biotech shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 1.9% of Moleculin Biotech shares are held by company insiders. Comparatively, 6.9% of Xyratex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is MBRX or XRTX more profitable? Xyratex's return on equity of -146.27% beat Moleculin Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Moleculin BiotechN/A -157.44% -97.16% Xyratex N/A -146.27%-86.83% Which has more risk & volatility, MBRX or XRTX? Moleculin Biotech has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Does the media refer more to MBRX or XRTX? In the previous week, Xyratex had 1 more articles in the media than Moleculin Biotech. MarketBeat recorded 3 mentions for Xyratex and 2 mentions for Moleculin Biotech. Moleculin Biotech's average media sentiment score of 1.04 beat Xyratex's score of 0.00 indicating that Moleculin Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moleculin Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Xyratex 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, MBRX or XRTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMoleculin BiotechN/AN/A-$29.77MN/AN/AXyratexN/AN/A-$2.16M-$1.35-0.70 SummaryMoleculin Biotech beats Xyratex on 7 of the 13 factors compared between the two stocks. Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXyratexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.61M$6.46B$5.33B$8.31BDividend YieldN/A2.63%5.27%4.11%P/E Ratio-0.708.3626.7119.59Price / SalesN/A258.94395.59135.06Price / CashN/A65.8538.3234.62Price / Book0.416.416.764.50Net Income-$2.16M$143.73M$3.23B$248.40M Xyratex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXyratex0.4222 of 5 stars$0.95-4.9%N/A-61.5%$3.61MN/A-0.70N/AMBRXMoleculin Biotech2.1779 of 5 stars$0.98-1.4%$6.00+512.3%-81.0%$13.84MN/A0.0020Positive NewsEQEquillium2.618 of 5 stars$0.39+0.3%$3.00+678.6%-71.0%$13.76M$41.10M-2.7540Gap DownPRPHProPhase Labs1.8285 of 5 stars$0.33+2.2%N/A-94.0%$13.72M$6.77M-0.26130Earnings ReportGap DownHigh Trading VolumeIBIOiBio1.1569 of 5 stars$0.82+2.7%$4.30+423.9%-63.1%$13.56M$375,000.000.00100Gap DownME23andMeN/A$0.50-35.3%N/A-95.1%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeUBXUnity Biotechnology3.6375 of 5 stars$0.77-4.2%$4.25+448.5%-46.6%$13.34M$240,000.00-0.5960SYBXSynlogicN/A$1.13+4.6%N/A-28.5%$13.22M$8,000.00-0.2780Upcoming EarningsBCTXBriaCell Therapeutics1.2764 of 5 stars$3.56+11.3%$32.00+798.9%-85.7%$13.20MN/A-0.278Gap DownMRKRMarker Therapeutics4.2152 of 5 stars$1.14+0.9%$13.17+1,055.0%-72.0%$12.90M$6.59M-0.8660BOLTBolt Biotherapeutics3.0884 of 5 stars$0.33+0.6%$2.50+658.3%-58.4%$12.64M$7.69M-0.1990Analyst ForecastGap Down Related Companies and Tools Related Companies MBRX Alternatives EQ Alternatives PRPH Alternatives IBIO Alternatives ME Alternatives UBX Alternatives SYBX Alternatives BCTX Alternatives MRKR Alternatives BOLT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
